In PD, however, there is not enough evidence to support its use as early diagnostic biomarker22 and, similarly to our findings, some studies have failed to demonstrate a difference in plasma NfL among PD and HC31,32, despite its utility in discriminating PD from APD24,30. This evidence concerns the gene NEFL and Parkinson disease.